D027 CCM1 CPE Activity: Phases 1-3 Synthesis & Feedback Summaries

D027 CCM1 CPE Activity: Phases 1-3 Synthesis & Feedback Summaries

Student Name

Western Governors University

D027 Advanced Pathopharmacological Foundations

Prof. Name:

Date

D027 CCM1 CPE Activity: Phases 1-3 Synthesis & Feedback Summaries

Phase 1: Timeline and Estimated Completion

Task Description	Proposed Completion Date	Estimated Time to Complete
1a. CPE schedule table	06/10/2024	30 minutes
1b. Feedback and Synthesis Improvement Plan	06/25/2024	2 hours
1b. Pathophysiology Synthesis	06/25/2024	2 hours
1c. Three screenshots of GoReact and reflection	06/25/2024	1.5 hours

Phase 2: Timeline and Estimated Completion

Task Description	Proposed Completion Date	Estimated Time to Complete
2a. Review CPE schedule table for progress	06/30/2024	30 minutes
2b. Feedback and Synthesis Improvement Plan	06/30/2024	2 hours
2b. Patient or Healthcare Consumer-Focused Synthesis	06/30/2024	2 hours
2c. Three screenshots of GoReact and reflection	06/30/2024	1.5 hours

Phase 3: Timeline and Estimated Completion

Task Description	Proposed Completion Date	Estimated Time to Complete
3a. Review CPE schedule table for progress	07/04/2024	30 minutes
3b. Feedback and Synthesis Improvement Plan	07/04/2024	2 hours
3b. Preceptor or Colleague-Focused Synthesis	07/04/2024	2 hours
3c. Feedback and Synthesis Improvement Plan	07/04/2024	2 hours
3c. Patient or Healthcare Consumer-Focused Treatment Plan	07/04/2024	2 hours
3d. Three screenshots of GoReact and reflection	07/04/2024	2 hours

---

Phase 1. 1B: Advanced Professional Nurse or Colleague Pathophysiology Synthesis

What is Chronic Lower Respiratory Infection, and What Are Its Pathophysiological Mechanisms?

Chronic lower respiratory infections represent a group of persistent lung diseases that inflame and damage the lower airways, causing ongoing respiratory symptoms and decreased lung capacity (WHO, 2017). The pathophysiology varies among conditions:

• Chronic Obstructive Pulmonary Disease (COPD) results mainly from prolonged exposure to harmful substances such as tobacco smoke. This exposure triggers chronic inflammation, bronchitis, and emphysema.

• Bronchiectasis is characterized by irreversible widening and damage of airways, often due to recurrent infections.

• Chronic pneumonia involves persistent infection and inflammation caused by various pathogens (Wheeldon, 2023).

What Are the Clinical Manifestations and Diagnostic Procedures?

Patients typically present with persistent cough, sputum production, wheezing, breathlessness, and repeated infections. Advanced disease stages may lead to weight loss, exercise intolerance, and respiratory failure (Mandell & Read, 2010).

Diagnosis requires a multifaceted approach involving:

• Clinical examination and pulmonary function tests such as spirometry,

• Imaging studies including chest X-rays and CT scans,

• Microbiological tests like sputum cultures to identify causative pathogens (Mahashur, 2018).

How Are Chronic Lower Respiratory Infections Treated?

Treatment goals focus on symptom relief, disease progression control, and lung function improvement. Management strategies vary:

• COPD: Smoking cessation, bronchodilators, corticosteroids, pulmonary rehabilitation, and vaccinations (National Heart Lung and Blood Institute, 2023).

• Bronchiectasis: Airway clearance techniques, targeted antibiotics, addressing underlying causes, and immunization.

• Chronic pneumonia: Appropriate antibiotic therapy based on pathogen identification, supportive care, and vaccinations (Mandell & Read, 2010).

---

Feedback on the Synthesis

Healthcare providers reviewed the pathophysiology synthesis of chronic lower respiratory infections. They found it clear, organized, and informative, effectively covering etiology, clinical presentation, diagnostic strategies, and treatments. Despite the positive reception, no specific recommendations for improvement were provided. This feedback suggests that the synthesis successfully met educational objectives.

The providers demonstrated a thorough understanding by accurately summarizing key disease aspects, which confirms the synthesis’s effectiveness. Future educational efforts should continue using this model to ensure clarity and comprehensiveness.

---

Phase 1C: GoReact Video Reflection Summary

The synthesis on chronic lower respiratory infections was developed to educate healthcare providers comprehensively. Drawing from clinical experience as a Medical-Surgical Telemetry nurse, the material was carefully researched and supported by scholarly references.

Challenges included condensing vital information into a concise one-page format without sacrificing depth. The feedback from peers was overwhelmingly positive, appreciating the clear, organized presentation that made complex information accessible.

A limitation noted was that the reviewers were already familiar with the topic, potentially limiting suggestions for further improvement. Nonetheless, their ability to articulate the key points indicated strong comprehension.

---

Phase 2. 2B: Patient or Healthcare Consumer-Focused Synthesis

What Is a Stroke and What Are Its Types?

A stroke, or cerebrovascular accident (CVA), occurs when brain blood supply is disrupted by either a blockage (ischemic stroke) or a blood vessel rupture (hemorrhagic stroke), leading to brain cell damage or death (American Heart Association, 2021).

What Are the Signs and Symptoms?

Stroke symptoms depend on the brain area affected but commonly include:

• Sudden weakness or numbness on one side,

• Difficulty with speech or comprehension,

• Severe headache,

• Loss of balance,

• Vision problems.

The mnemonic F-A-S-T (Facial drooping, Arm weakness, Slurred speech, Time to call 911) aids in early recognition (National Institute of Neurological Disorders and Stroke, n.d.).

How Is Stroke Diagnosed?

Diagnosis includes clinical evaluation, medical history, and imaging tests such as CT scans or MRIs to identify stroke type and location. Blood tests assess underlying risk factors (American Heart Association, 2021).

What Treatments Are Available?

Prompt treatment aims to restore brain blood flow:

• Ischemic stroke: Thrombolytic therapy with tPA or mechanical thrombectomy.

• Hemorrhagic stroke: Control bleeding, relieve brain pressure, surgical repair.

• Post-acute rehabilitation focuses on physical, occupational, and speech therapies.

What Preventive Measures Are Recommended?

Lifestyle modifications and chronic disease management (blood pressure control, healthy diet, smoking cessation, physical activity) reduce stroke risk (National Institute of Neurological Disorders and Stroke, n.d.).

---

Feedback from Healthcare Consumers

Healthcare consumers found the stroke synthesis clear and educational, expressing appreciation for the practical information on stroke signs and responses. They suggested enhancing readability by highlighting key terms in bold to improve retention.

Consumers demonstrated solid comprehension by summarizing the stroke’s causes, symptoms, diagnosis, and treatment in their own words, confirming the synthesis’s effectiveness in patient education.

---

Phase 2C: GoReact Video Reflection Summary

The stroke synthesis was designed for healthcare consumers with the intent to simplify complex medical information. The greatest challenge was reducing the content to one page while ensuring accessibility to non-healthcare readers.

Feedback was positive, with consumers valuing the clarity and brevity. The suggestion to bold key terms supports interactive learning, promoting better retention. This experience reinforced the importance of tailoring health education to the audience’s literacy level.

---

Phase 3: 3B Advanced Professional Nurse or Colleague Synthesis and Patient Treatment Plan

Case Overview: COPD Patient Ms. O’Connor

Ms. O’Connor, aged 55, presents with worsening COPD symptoms, including productive cough and bronchospasm. Despite attempts with nicotine replacement therapy, she continues to smoke 3-5 cigarettes daily. Her spirometry shows FEV1 of 1.37 L (49% predicted). She has a family history of smoking-related illnesses and significant weight gain over two years.

What Is COPD Pathophysiology?

COPD is a chronic inflammatory lung disease caused by inhalation of harmful particles, leading to airway narrowing, reduced lung elasticity, and air trapping (Agarwal et al., 2023). Structural changes cause symptoms like cough, dyspnea, and sputum production.

What Are the Common Signs and Symptoms?

Symptoms include shortness of breath, chronic cough, wheezing, increased mucus, decreased exercise tolerance, barrel chest, cyanosis, and clubbing (Agarwal et al., 2023).

How Is COPD Diagnosed?

Diagnosis relies on:

• Clinical assessment and symptom evaluation,

• Pulmonary function tests such as spirometry,

• Imaging (chest X-ray, CT scan),

• Arterial blood gas analysis,

• Testing for alpha-1 antitrypsin deficiency (Agarwal et al., 2023).

What Are the Treatment Options and Potential Medication Side Effects?

Treatment focuses on symptom control, exacerbation prevention, and lifestyle modification:

Treatment Type	Medication Examples	Purpose	Potential Side Effects
Bronchodilators	Short-acting: Albuterol	Relax airways	Tremors, tachycardia, headaches
	Long-acting: Tiotropium	Maintain open airways	Dry mouth, cough
Inhaled Corticosteroids	Formoterol	Reduce airway inflammation	Thrush, hoarseness (mouthwash recommended)
Smoking Cessation	Bupropion	Aid quitting smoking	Insomnia, dry mouth, tremors, seizures risk

Non-pharmacological interventions include pulmonary rehabilitation and vaccinations (Agarwal et al., 2023).

---

Feedback on COPD Synthesis and Treatment Plan

Colleague feedback praised the synthesis for clarity, comprehensive coverage, and readability. Highlighting key terms in bold was noted as beneficial for retention.

Engagement with the Shadow Health simulation enhanced clinical understanding, assessment skills, and confidence in managing COPD patients. The experience underscored the critical role of patient education in improving health outcomes.

References

• Agarwal, A. K., Raja, A., & Brown, B. D. (2023, August 7). Chronic obstructive pulmonary disease. StatPearls. https://www.ncbi.nlm.nih.gov/books/NBK559281/

• American Heart Association. (2021). About stroke. American Stroke Association. https://www.stroke.org/en/about-stroke

• Mahashur, A. (2018). Management of lower respiratory tract infection in outpatient settings: Focus on clarithromycin. Lung India, 35(2), 143–149. https://doi.org/10.4103/lungindia.lungindia_262_17

• Mandell, L. A., & Read, R. C. (2010). Infections of the lower respiratory tract. In Antibiotic and Chemotherapy (pp. 574–588). https://doi.org/10.1016/B978-0-7020-4064-1.00045-2

• National Heart Lung and Blood Institute. (2023). Treatment. https://www.nhlbi.nih.gov/health/copd/treatment

• National Institute of Neurological Disorders and Stroke. (n.d.). Signs and symptoms. https://www.ninds.nih.gov/health-information/stroke/signs-and-symptoms

• National Institute of Neurological Disorders and Stroke. (n.d.). Assess and treat. https://www.ninds.nih.gov/health-information/stroke/assess-and-treat

• National Institute of Neurological Disorders and Stroke. (n.d.). Prevention. https://www.ninds.nih.gov/health-information/stroke/prevention

• U.S. National Library of Medicine. (n.d.). Albuterol oral inhalation: Medlineplus Drug Information. https://medlineplus.gov/druginfo/meds/a682145.html

• U.S. National Library of Medicine. (n.d.). Tiotropium oral inhalation: Medlineplus Drug Information. https://medlineplus.gov/druginfo/meds/a604018.html

• U.S. National Library of Medicine. (n.d.-c). Formoterol oral inhalation: Medlineplus Drug Information. https://medlineplus.gov/druginfo/meds/a602023.html

• U.S. National Library of Medicine. (n.d.). Bupropion: Medlineplus Drug Information. https://medlineplus.gov/druginfo/meds/a695033.html

• Wheeldon, A. (2023). The respiratory system and associated disorders. British Journal of Nursing, 32(13), 613–619. https://doi.org/10.12968/bjon.2023.32.13.613

• World Health Organization (WHO). (2017). Chronic obstructive pulmonary disease (COPD). https://www.who.int/news-room/fact-sheets/detail/chronic-obstructive-pulmonary-disease-(copd)